TrialCirculation2020

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.

Mikhail N Kosiborod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.